The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
Open accessAbstract
The pathogenesis of multiple sclerosis (MS), an autoimmune disease affecting the brain and spinal cord, remains poorly understood. Patients with MS typically present with recurrent episodes of neurological dysfunctions such as blindness, paresis, and sensory disturbances. Studies on experimental autoimmune encephalomyelitis (EAE) animal models have led to a number of testable hypotheses including a hypothetical role of altered gut microbiota in the development of MS. To investigate whether gut microbiota in patients with MS is altered, we compared the gut microbiota of 20 Japanese patients with relapsing-remitting (RR) MS (MS20) with that of 40 healthy Japanese subjects (HC40) and an additional 18 healthy subjects (HC18). All the HC18 subjects repeatedly provided fecal samples over the course of months (158 samples in total). Analysis of the bacterial 16S ribosomal RNA (rRNA) gene by using a high-throughput culture-independent pyrosequencing method provided evidence of a moderate dysbiosis in the structure of gut microbiota in patients with MS. Furthermore, we found 21 species that showed significant differences in relative abundance between the MS20 and HC40 samples. On comparing MS samples to the 158 longitudinal HC18 samples, the differences were found to be reproducibly significant for most of the species. These taxa comprised primarily of clostridial species belonging to Clostridia clusters XIVa and IV and Bacteroidetes. The phylogenetic tree analysis revealed that none of the clostridial species that were significantly reduced in the gut microbiota of patients with MS overlapped with other spore-forming clostridial species capable of inducing colonic regulatory T cells (Treg), which prevent autoimmunity and allergies; this suggests that many of the clostridial species associated with MS might be distinct from those broadly associated with autoimmune conditions. Correcting the dysbiosis and altered gut microbiota might deserve consideration as a potential strategy for the prevention and treatment of MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures




![Fig 5 Phylogenetic tree of 14 clostridial species exhibiting significant differences among groups and several known species. The neighbor-joining method was used to construct the phylogenetic tree. Numbers at each node indicate the bootstrap support (1,000 replicates). Those written in red letters are 14 clostridial species having a significant difference in relative abundance between HC40 and MS20 samples. Treg-inducing strains are indicated by “St” and are written in blue letters [13].](/paper-figures/cabefd3c1856464fb7f6cfb12c4b3815/dysbiosis-in-the-gut-microbiota-of-patients-with-multiple-sclerosis-with-a-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacteria belonging to the Clostridia family contribute to the suppression of pathological autoimmunity (134, 139–143).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [134]
In the citing paper
“Interestingly, even MS patients with active disease have an altered microbiota compared to patients in the remission phase, which in turn have a microbiota more similar to healthy controls (25, 134–138).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Cited by
Sorted by citations
Items 601–700 of 810
Gao, Q., Xiong, M., Zhou, S., Lu, J., Ren, B., Peng, Q., Zeng, M., & Song, H. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1749111 · Cited by 3
Cellular Immunity and Multiple Sclerosis: Current Understanding
Sato, W., & Yamamura, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-55594-0_1 · Cited by 2
Gut Dysbiosis and Its Treatment in Patients with Functional Dyspepsia
Naito, Y., Fukui, A., Kashiwagi, S., & Takagi, T. (2018) · Springer eBooks · doi:10.1007/978-981-13-1074-4_14 · Cited by 3
La asociación entre microbioma intestinal y uveítis autoinmune
Kalogeropoulos, D., Barry, R. J., & Kalogeropoulos, C. D. (2022) · Archivos de la Sociedad Española de Oftalmología · doi:10.1016/j.oftal.2021.01.019 · Cited by 3
Potential Role of Probiotics on Gut Microbiota in Neurological Disease
Jose, J. V., & Aliya, S. (2022) · Nutritional neurosciences · doi:10.1007/978-981-19-4530-4_10 · Cited by 3
Watai, K., Suda, W., Kurokawa, R., Sekiya, K., Hayashi, H., Iwata, M., Nagayama, K., Nakamura, Y., Hamada, Y., Kamide, Y., et al. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03239-y · Cited by 4
Eggerthella lenta down regulated flavone and flavonol biosynthesis promoted Kawasaki disease
Yeh, Y., Chen, K.-D., Huang, C., Tsai, J.-R., & Kuo, H. (2025) · Virulence · doi:10.1080/21505594.2025.2512401 · Cited by 3
McDonald, J. E., Harris, R. N., Doonan, J., Carryl, S. S., Sze, M. A., McKenzie, V. J., & Gilbert, J. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108654418.007 · Cited by 3
Microbiota-Gut-Brain Axis in Neurological Disorders
Sundaram, S., Ponnambath, D. K., & Nair, S. S. (2022) · Springer eBooks · doi:10.1007/978-981-16-7672-7_7 · Cited by 4
Joscelyn, J., Ochoa‐Repáraz, J., & Kasper, L. H. (2019) · Current clinical neurology · doi:10.1007/978-3-030-24436-1_2 · Cited by 3
Gut microbiota and COVID-19: An intriguing pediatric perspective
Valentino, M. S., Esposito, C., Colosimo, S., Caprio, A. M., Puzone, S., Guarino, S., Marzuillo, P., del Giudice, E. M., & Sessa, A. D. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i23.8076 · Cited by 3
Prospects for the use of polyphenols in multiple sclerosis
Lopatina, A., Kukushkina, A. D., Melnikov, M., & Rogovskii, V. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212207236 · Cited by 3
Ladakis, D. C., & Bhargava, P. (2023) · CNS Drugs · doi:10.1007/s40263-023-00986-w · Cited by 6
Dysbiosis in Multiple Sclerosis: Can Immunoglobulin Y Supplements Help?
Paraschiv, A.-C., Văcăraș, V., Nistor, C., Văcăraș, C., Nistor, D.-T., Vesa, Ș. C., Iluţ, S., & Muresanu, D. F. (2024) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-5241 · Cited by 3
Ferri, I., Dell'Anno, M., Quiese, A., Castiglioni, B., Cremonesi, P., Biscarini, F., Canala, B., Santoru, M., Colombini, A., Ruffo, G., et al. (2024) · Veterinary research communications · doi:10.1007/s11259-024-10588-6 · Cited by 5
Role of effector T cells in multiple sclerosis
Chihara, N. (2020) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12594 · Cited by 3
The Nerves to Conduct a Multiple Sclerosis Crime Investigation
Chopra, S., Myers, Z., Sekhon, H., & Dufour, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052498 · Cited by 2
Microbiome Based Diseases Diagnostics
Yadav, M., & Bhambi, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00012-7 · Cited by 3
Shimizu, J., & Suzuki, N. (2016) · Biomedical Research and Clinical Practice · doi:10.15761/brcp.1000113 · Cited by 3
Disease of the holobiont, the example of multiple sclerosis
Castillo-Álvarez, F., & Marzo-Sola, M. E. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.08.012 · Cited by 3
Mapping the Environmental Microbiome
Takayasu, L., Suda, W., & Hattori, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20071-x · Cited by 3
Mining for disease-associated microbial metabolites in an age-dependent model of multiple sclerosisPreprint
Pu, A., Fettig, N. M., Polyzois, A., Chao, G. Y. C., Naouar, I., Hohman, L. S., Fontaine, M. A., Zuo, M., Champagne-Jorgensen, K., Copeland, J. K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.27.595846 · Cited by 3
«Gut-brain» axis and multiple sclerosis
Omarova, М. А., & Boyko, A. N. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-6-122-127 · Cited by 2
Zhang, S., Chen, W., Ma, C., Luo, Y., Dong, L., Hu, X., Chen, F., & Li, D. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250215 · Cited by 2
Barak, N., Brekhman, V., Aharonovich, D., Lotan, T., & Sher, D. (2025) · Environmental Microbiome · doi:10.1186/s40793-025-00714-5 · Cited by 4
Alshinnawy, A. S., Badiea, E. A., Swelam, M. S., Sayed, A. A., & Mohamed, M. R. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05194-9 · Cited by 2
Naito, H., Nakamori, M., Nishi, H., Toko, M., Muguruma, T., Yamada, H., Sugimoto, T., Yamazaki, Y., Ochi, K., Kawaguchi, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-22266-x · Cited by 4
Effect of diroximel fumarate on gut dysbiosis and autoimmunity in the central nervous system
Yadav, S. K., Ito, N., Suresh, S., Rosario, Y., Kalina, J. T., Shankar, S. L., Ito, K., & Dhib-Jalbut, S. S. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116054 · Cited by 2
Hill, K., LaFollette, A., Kirby, T. O., Negrete, S., Babcock, D., Felton, K., Kohl, H. M., Sharma, K., Castillo, A., Roullet, J.-B. O., et al. (2026) · FASEB BioAdvances · doi:10.1096/fba.2025-00082 · Cited by 2
Hou, Y., Wang, H., He, X., Zhang, M., Sheng, J., Chen, W., Wu, Y., & Zheng, C. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150175 · Cited by 2
Ansari, M. M., Min, Y., Ko, E., Kwon, D., Khan, R., & Son, Y. (2026) · Advanced NanoBiomed Research · doi:10.1002/anbr.202500233 · Cited by 2
The Japanese gut microbiome: ecology, uniqueness, and impact on health and disease
Nishijima, S., Hattori, M., & Nagata, N. (2026) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.102.006 · Cited by 3
Ricaurte‐Fajardo, A., Gonzalez, K. G., Campo, S. M., la Hoz, C. A.-D., Cárdenas, A. M., & Zarco, L. A. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.125865 · Cited by 2
Wray, C., Castañeda-Monsalve, V., Engelmann, B., Rolle-Kampczyk, U. E., Schweiger, N., Gutsfeld, S., Ghosh, D., Kader, S., Tyler, C. R., Jehmlich, N., et al. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag022 · Cited by 1
Rao, X., Zou, L., Cai, X., Yao, Y., & Zhong, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1761834 · Cited by 2
Gut Microbiota and Autoimmune Diseases: The Therapeutic Potential of Probiotics
Domagała, A., & Kiecka, A. (2026) · Current Microbiology · doi:10.1007/s00284-026-04992-1 · Cited by 2
Gut microbiota modification as an option in multiple sclerosis management
Zwiernik, B., Arłukowicz, T., Mycko, M. P., & Zwiernik, J. (2020) · Polish Annals of Medicine · doi:10.29089/2020.20.00133 · Cited by 2
Gut microbiota alterations and nutritional intervention in multiple sclerosis disease
Noguera-Navarro, C., Navas-Carrillo, D., & Orenes‐Piñero, E. (2022) · Food Reviews International · doi:10.1080/87559129.2022.2062771 · Cited by 2
Abdurasulova, I. N. (2023) · Medical academic journal · doi:10.17816/maj115019 · Cited by 2
Hussain, N., & Muccee, F. (2024) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2024.103939 · Cited by 2
The Gut Microbiome and the Central Nervous System (CNS)
Vijay, A., Ahmad, F., Sudesh, R., & Balakrishnan, A. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_3 · Cited by 2
Prospects for microbiome modulation in autoimmune diseases: a literature review
Peshkova, M., Korneev, A. A., Игоревна, К. П., Kosheleva, N. V., & Timashev, P. S. (2024) · Sechenov Medical Journal · doi:10.47093/2218-7332.2024.15.1.4-19 · Cited by 2
Effect of microbial dysbiosis on autoimmune associated inflammation
Singh, K., & Bhadauriya, A. S. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2024.12.016 · Cited by 3
Ahmad, I., Omura, S., Khadka, S., Sato, F., Park, A.-M., Rimal, S., & Tsunoda, I. (2025) · Cells · doi:10.3390/cells14120871 · Cited by 4
The role of gut microbiota and diet in experimental autoimmune encephalitis and multiple sclerosis
Okuno, T., Nakatsuji, Y., Kinoshita, M., Takata, K., Koda, T., Yamashita, K., Nanba, A., & Mochizuki, H. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12270 · Cited by 2
Anderson, G., & Maes, M. H. J. (2016) · CRC Press eBooks · doi:10.1201/9781315369334-42 · Cited by 2
Abdurasulova, I. N., Matsulevich, A. V., Тарасова, Е. А., Kudryavtsev, I. V., Nikiforova, I. G., Serebryakova, M. K., Miroshnichenko, M. I., Ивашкова, Е. В., Tatarinov, A. E., Ilves, A. G., et al. (2019) · Medical academic journal · doi:10.17816/maj191s151-54 · Cited by 2
Leech, B., McEwen, B. J., & Sekyere, E. O. (2020) · Alternative and Complementary Therapies · doi:10.1089/act.2020.29278.ble · Cited by 2
Neurodegenerative Diseases and the Gut Microbiota
Cabré, S., O’Riordan, K. J., & Cryan, J. F. (2022) · Progress in inflammation research · doi:10.1007/978-3-030-91051-8_11 · Cited by 2
Microorganisms in Pathogenesis and Management of Acute Disseminated Encephalomyelitis (ADEM)
Agrawal, A., & Bhattacharyya, S. (2022) · Springer eBooks · doi:10.1007/978-981-19-4800-8_11 · Cited by 2
Emerging Relationship Between the Gut Microbiota and Neurodegenerative Disorders
Iyer, S., Verma, S., Marathe, S. A., & Tare, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_11 · Cited by 2
Тиреоидит Хашимото: современные взгляды на патогенез (обзор литературы)
SHIDLOVSKYI, V. O., Shidlovskyi, А. V., Sheremet, M. I., Sydorchuk, L., & Pankiv, І. V. (2020) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.16.4.2020.208489 · Cited by 2
D’Amato, A., Mannelli, L. D. C., Lucarini, E., Man, A., Gall, G. L., Branca, J., Ghelardini, C., Amedei, A., Bertelli, E., Regoli, M., et al. (2019) · Nottingham Trent University's Institutional Repository (Nottingham Trent Repository) · doi:10.1101/866459 · Cited by 2
Cao, S., Budina, E., Raczy, M. M., Solanki, A., Nguyen, M., Beckman, T. N., Reda, J. W., Hultgren, K., Ang, P. S., Slezak, A. J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.28.538720 · Cited by 2
Gut Microbiome Structure and Progression in Multiple Sclerosis: A Meta-Analysis Across 14 COHORTSPreprint
Doms, S., Baines, J. F., & Hendriks, J. J. A. (2025) · medRxiv · doi:10.1101/2025.09.08.25335213 · Cited by 2
Gut environment and multiple sclerosis
Miyake, S., & Noto, D. (2021) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001590 · Cited by 1
Microflora impacts immune system and its antitumor function
Rawat, P., Dhingra, M., Kosta, K., & Das, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96128-8.00007-9 · Cited by 1
The microbiome-gut-brain axis in multiple sclerosis
Radojević, D., Bajić, S. S., Dinić, M., Bisenić, A., Đokić, J., & Golić, N. (2023) · Arhiv za farmaciju · doi:10.5937/arhfarm73-46986 · Cited by 1
Abdurasulova, I. N., Chernyavskaya, E. A., Nikitina, V., Ivanov, A. B., Lioudyno, V. I., Nartova, A. A., Matsulevich, A. V., Skripchenko, E. Y., Бисага, Г. Н., Игоревич, У. В., et al. (2024) · Журнал эволюционной биохимии и физиологии · doi:10.31857/s0044452924010098 · Cited by 1
Abdurasulova, I. N. (2024) · Medical academic journal · doi:10.17816/maj633511 · Cited by 1
Messadi, A., Sayhi, S., Ghedira, K., Zaouaoui, C., Arfaoui, B., Khouikhi, S., Rebai, M., Guediche, N., Abdelhafidh, N. B., Louzir, B., et al. (2025) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2025.04.002 · Cited by 1
Zhang, X., Li, M., Luo, Y., Li, N., & Wang, Z. (2025) · Interdisciplinary Nursing Research · doi:10.1097/nr9.0000000000000108 · Cited by 1
Abdurasulova, I. N., Matsulevich, A. V., Grefner, N. M., Трофимов, А. Н., Kudryavtsev, I. V., & Ermolenko, E. I. (2025) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093025050059 · Cited by 1
Bynzar, V. V., Matsulevich, A. V., Grefner, N. M., Новікова, Н. В., & Abdurasulova, I. N. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-239-7-162-181 · Cited by 1
Lv, J., Liu, R., Sun, Z., Zhang, J., Zhang, Y., Zhao, X., Liu, J., Zhou, X., Zhang, M., Liu, Q., et al. (2026) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x26500023 · Cited by 1
Research on metabolic characteristics of multiple sclerosis
Wang, D., Feng, W., Wang, H., Ying, X., Cai, W., Guo, L., Hou, J., & Yang, T. (2026) · Scientific Reports · doi:10.1038/s41598-026-42501-3 · Cited by 1
Hamdi, L., Agranyoni, O., Goldberg, Y., Zarka, N., Fainstein, N., Theotokis, P., Salamotas, I., Grigoriadis, N., Katz, A., Ben‐Hur, T., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-48522-2 · Cited by 1
Gut microbiota and gut-derived metabolites in defining multiple sclerosis phenotypic continuum
Montini, F., Mangalam, A. K., Zeydan, B., Murray, J., & Kantarci, O. H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1858047 · Cited by 1
Nutrition, Macrobiotics, and the Brain’s Neuroinflammatory Response
Arsenescu, V. (2016) · Springer eBooks · doi:10.1007/978-3-319-28609-9_8 · Cited by 1
5) Gut Microbiota and Multiple Sclerosis
Yamamura, T. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.113b · Cited by 1
Human Microbiota and Autoimmune Diseases
Resende, G. G., & de Carvalho, J. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814307-0.00020-7 · Cited by 1
Using Data Science for Medical Decision Making Case: Role of Gut Microbiome in Multiple Sclerosis
Telalović, J. H., & Kilic, A. M. (2019) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-17971-7_54 · Cited by 1
Dalmau, J. O., Dalakas, M. C., Kolson, D. L., Paul, F., & Zamvil, S. S. (2019) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000644 · Cited by 1
Microbiota and Neurodegenerative Diseases
Khan, M. F., & Banerjee, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00098-x · Cited by 1
Gut Microbiome Composition as the Key Factor for Immunomodulation in the Host
Bhat, M. I., Kumari, A., Kapila, S., & Kapila, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-1626-6_7 · Cited by 1
Yamamura, T., & Takewaki, D. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103870 · Cited by 1
Dietary restriction in multiple sclerosis: evidence from preclinical and clinical studies
Liao, E., Ghezzi, L., & Piccio, L. M. (2022) · Advances in Clinical Neuroscience & Rehabilitation · doi:10.47795/mcln8939 · Cited by 1
5) Gut Microbiota and Multiple Sclerosis
Yamamura, T. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.1717 · Cited by 1
Progress in the Influence of Intestinal Flora on Disease-Related Studies
王, 艳. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.125686 · Cited by 1
Gut Microbiota Changes and Parkinson’s Disease: What Do We Know, Which Avenues Ahead
Hirayama, M., & Ohno, K. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-14023-5_13 · Cited by 1
Women in the field of multiple sclerosis: How they contributed to paradigm shifts
Barateiro, A. P., Barros, C., Pinto, M. V., Ribeiro, A. R., Alberro, A., & Fernandes, A. M. A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1087745 · Cited by 1
Linking diet and gut microbiota in multiple sclerosis
Bitarafan, S., Harirchian, M. H., Farahbakhsh, P., & Soltani, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89834-8.00020-9 · Cited by 1
Gut Microbiota and Altered Behaviour: Target on Neuroimmune Interplays
Jayaraman, S., & Paul, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_9 · Cited by 5
Update Review of the Relationship Between Gut Microbiota and Neurodegenerative Diseases
Wang, Y., Jing, G., Fu, Y., Li, Y., & Wu, C. (2024) · Diseases & Research · doi:10.54457/dr.202401007 · Cited by 1
Interplay Between Gut-microbiota and Neurodegeneration
Ashique, S., Pal, R., Kumar, S., Verma, B., Kumar, N., Kahwa, I., Farid, A., Mishra, N., Kumar, P., & Taghizadeh‐Hesary, F. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238754124010009 · Cited by 1
Role of microbiota-gut-brain axis in autoimmunity and multiple sclerosis
Mishra, Y., Maity, D., & Kaundal, R. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21680-0.00007-9 · Cited by 1
The microbiome: what a neurologist needs to know
Dehghanizai, A. B., Stewart, C. J., & Thomas, R. H. (2025) · Practical Neurology · doi:10.1136/pn-2024-004400 · Cited by 1
Berdanier, C. D. (2018) · Nutrition Today · doi:10.1097/nt.0000000000000276 · Cited by 1
Hiseni, P., Wilson, R. C., Storr⊘, O., Johnsen, R., Øien, T., & Rudi, K. (2019) · BioTechniques · doi:10.2144/btn-2018-0134 · Cited by 1
Duscha, A., Gisevius, B., Hirschberg, S., Haase, S., Stangl, G. I., Berg, J., David, C., Schneider, R., Dokalis, N., Staszewski, O., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3293683 · Cited by 1
Islam, M. Z., Tran, M. A., Xu, T., Tierney, B. T., Patel, C. J., & Kostic, A. D. (2021) · Research Square · doi:10.21203/rs.3.rs-1195626/v1 · Cited by 1
Association Between Polygenic Risk Score And Gut Microbiome Of Multiple SclerosisPreprint
Elsayed, N. S., Valenzuela, R. K., Kitchner, T., Le, T. N., Mayer, J. G., Tang, Z.-Z., Bayanagari, V. R., Lu, Q., Aston, P., Anantharaman, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.07.515482 · Cited by 1
Shrode, R. L., Ollberding, N. J., & Mangalam, A. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.21.549984 · Cited by 1
Horizontal gene transfer shapes pathogenic bacteria in multiple sclerosisPreprint
Yamamura, T., Takewaki, D., Kiguchi, Y., Masuoka, H., Manu, M. S., Raveney, B. J. E., Narushima, S., Kurokawa, R., Ogata, Y., Kimura, Y., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3716024/v1 · Cited by 1
Gut Microbiota: A Possible Role in the Pathogenesis of Multiple Sclerosis
Yamamura, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-28609-9_10
Defective Immune Regulation in Multiple Sclerosis: E3 Ubiquitin Ligase Cbl-b and TLR Tolerance
Fujiwara, M. (2017) · OpenCommons - UConn (University of Connecticut)
Akingbade, O. A. (2022) · Digital Archive @ GSU · doi:10.57709/10502298
Causality and complex disease: The example of multiple sclerosis
Bach, J. (2017) · Revue Neurologique · doi:10.1016/j.neurol.2017.07.011
Diät, Mikrobiom und Multiple Sklerose
Haghikia, A., & Linker, R. A. (2018) · Aktuelle Neurologie · doi:10.1055/s-0043-111789
Diet, Microbiome and Multiple Sclerosis
Haghikia, A., & Linker, R. A. (2018) · Neurology International Open · doi:10.1055/s-0043-111782
Metadata
- Authors
- Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., Morita, H., Hattori, M., & Yamamura, T.
- Affiliations
- Juntendo University (JP)
- RIKEN Center for Integrative Medical Sciences (JP)
- The University of Tokyo (JP)
- National Institute of Neuroscience (JP)
- Azabu University (JP)
- Corresponding author
- Hattori, Masahira
- Yamamura, Takashi
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-09-14
- Volume
- 10
- Issue
- 9
- Pages
- e0137429
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4569432
- OpenAlex
- W2200372542
- Cited by
- 809
- References
- 41
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 83 · 2023: 68 · 2022: 91 · 2021: 89 · 2020: 89 · 2019: 76 · 2018: 85 · 2017: 76 · 2016: 38 · 2015: 2
- FWCI
- 29.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministry of Health, Labour and Welfare
- University of Tokyo
- Japan Society for the Promotion of Science (24229006, 26293234)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- multiple sclerosis, gut microbiota, dysbiosis, Clostridium XIVa, Bacteroidetes, relapsing-remitting multiple sclerosis, experimental autoimmune encephalomyelitis, regulatory T cells, autoimmunity, 16S rRNA gene sequencing, fecal microbiota
- MeSH terms
- Gastrointestinal Microbiome, Adult, Clostridium, Female, Humans, Japan, Male, Multiple Sclerosis, RNA, Bacterial, RNA, Ribosomal, 16S, Sequence Analysis, RNA, Bacteroidetes, High-Throughput Nucleotide Sequencing, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review